je.st
news
Home › athersys
Tag: athersys
Investors perk up to promise of Athersys
2014-01-12 15:08:00| Biotech - Topix.net
Athersys Inc.'s stock price has more than doubled over the past two months, and that jump may be just a warm up if the Cleveland biotech company's adult stem cell technology passes two crucial tests this year.
Tags: promise
investors
perk
athersys
Athersys' MultiStem(R) Stem Cell Therapy Receives Orphan Drug Designation In Europe For Prevention Of Graft-Versus-Host Disease
2013-12-30 06:10:10| drugdiscoveryonline Home Page
Athersys, Inc. (Nasdaq:ATHX) announced today that the Committee for Orphan Medicinal Products of the European Medicines Agency (EMA) has issued a positive opinion (EMA/OD/146/13) for the Company's allogeneic, multipotent adult progenitor cell, or MultiStem® therapy, for the prevention of graft-versus-host disease (GvHD)
Tags: europe
cell
drug
disease
Sites : [1] [2]